PADI4 and systemic lupus erythematosus: In a murine model of SLE, NET inhibition by DNase I constrains the development of anti-ssDNA and anti-histone antibodies [189], and PAD4 inhibition by chloramidine reduces SLE-induced subsequent vascular injury and organ damage [190].